Form 4 for IDXX Idexx Laboratories
Accepted 2026-02-17 00:00:00 ET · period of report 2026-02-12 · accession 0000874716-26-000023 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2026-02-17 | 2026-02-14 | IDXX | Lane Michael | EVP | M - OptEx | $0.00 | +1,092 | 7,577 | +17% | $0 |
| D | 2026-02-17 | 2026-02-14 | IDXX | Lane Michael | EVP | F - Tax | $629.35 | -221 | 8,024 | -3% | -$139.1K |
| DM | 2026-02-17 | 2026-02-14 | IDXX | Lane Michael | EVP | M - OptEx | $0.00 | -1,092 | 602 | -64% | $0 |
| DM | 2026-02-17 | 2026-02-12 | IDXX | Lane Michael | EVP | A - Grant | $0.00 | +8,405 | 1,620 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-02-14 | M | A | 204 | $0.00 | 7,356.94 | D | — | — | (F1) Includes a total of 21 shares purchased under the Issuer Employee Stock Purchase Plan ('ESPP') on September 30, 2025 and December 31, 2025. There are a total of 252.944 shares held in the ESPP which has been increased by 0.005 shares due to a rounding calculation of previously issued fractional shares. |
| 2 | Common | Common Stock | 2026-02-14 | F | D | 221 | $629.35 | 8,023.94 | D | — | — | (F3) Closing price of Issuer common stock on Nasdaq Global Select Market on February 13, 2026. (F4) Includes 367 vested but deferred RSUs. |
| 3 | Common | Common Stock | 2026-02-14 | M | A | 367 | $0.00 | 8,244.94 | D | — | — | (F2) Represents Restricted Stock Units ('RSU') that were granted on February 14, 2025, were deferred in accordance with the Issuer's Deferred Compensation Plan and have vested. Upon vesting, these RSUs were recorded in an account under such Plan and represents a contingent right to receive one share of Issuer common stock that is payable as soon as practicable after the reporting person's termination of employment with the Issuer. |
| 4 | Common | Common Stock | 2026-02-14 | M | A | 301 | $0.00 | 7,877.94 | D | — | — | |
| 5 | Common | Common Stock | 2026-02-14 | M | A | 220 | $0.00 | 7,576.94 | D | — | — | |
| 6 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 367 | $0.00 | 1,101 | D | — · — to — | 367 Common Stock | (F10) Represents RSUs that were granted on February 14, 2025 and deferred in accordance with the Issuer's Deferred Compensation Plan and represents a contingent right to receive one share of Issuer common stock vesting in four annual installments, beginning February 14, 2026. Upon vesting, each such RSU will be recorded in an account under such Plan. |
| 7 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 204 | $0.00 | 0 | D | — · — to — | 204 Common Stock | (F11) Each RSU represents a contingent right to receive one share of Issuer common stock that vested in four annual installments, beginning February 14, 2023. |
| 8 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 220 | $0.00 | 220 | D | — · — to — | 220 Common Stock | (F12) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments, beginning February 14, 2024. |
| 9 | Derivative | Restricted Stock Unit | 2026-02-14 | M | D | 301 | $0.00 | 602 | D | — · — to — | 301 Common Stock | (F13) Each RSU represents a contingent right to receive one share of Issuer common stock and vests in four annual installments beginning on February 14, 2025. |
| 10 | Derivative | Restricted Stock Unit | 2026-02-12 | A | A | 1,262 | $0.00 | 1,262 | D | — · — to — | 1,262 Common Stock | (F8) Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in four annual installments, beginning February 14, 2027. |
| 11 | Derivative | Incentive Stock Option (right-to-buy) | 2026-02-12 | A | A | 162 | $0.00 | 162 | D | $617.20 · — to 2036-02-11 | 162 Common Stock | (F7) Grant of option to buy shares of Issuer common stock that becomes exercisable in one installment on February 14, 2030. |
| 12 | Derivative | Non-Qualified Stock Option (right-to-buy) | 2026-02-12 | A | A | 5,361 | $0.00 | 5,361 | D | $617.20 · — to 2036-02-11 | 5,361 Common Stock | (F6) Grant of option to buy shares of Issuer common stock that becomes exercisable in four annual installments beginning February 14, 2027. |
| 13 | Derivative | Restricted Stock Unit | 2026-02-12 | A | A | 1,620 | $0.00 | 1,620 | D | — · — to — | 1,620 Common Stock | (F9) Grant of RSUs that upon vesting, will be deferred and recorded in an account under the Issuer's Deferred Compensation Plan. This RSU grant vests in three annual installments, beginning February 14, 2027. |